NewsBite

Rear Window

Tom Richardson

Starpharma's coronavirus-fighting condoms

Tom RichardsonJournalist
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

COVID-19 has sure produced some unusual claims from companies at the speculative end of the sharemarket.

On Tuesday, loss-making biotech Starpharma pitched institutional investors at the Macquarie Australia Conference the efficacy of its SPL1703 gel ingredient as an antiviral agent in treating the coronavirus.

Loading...
Tom Richardson writes and comments on markets including equities, debt, crypto, software, banking, payments, and regulation. He worked in asset management at Bank of New York Mellon and is a member of the CFA Society of the UK as a holder of the Investment Management Certificate. Connect with Tom on Twitter. Email Tom at tom.richardson@afr.com
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Read More

Latest In Equity markets

Fetching latest articles

Most Viewed In Rear window

    Original URL: https://www.afr.com/rear-window/starpharma-s-coronavirus-fighting-condoms-20200505-p54pwh